CTRI/2017/06/008742已完成不适用
Evaluation of Dermatological safety of Investigational products by primary irritation patch test on healthy human volunteers of varied skin types
ITC Life Sciences Technology Centre1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年5月22日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Safety assessment of investigational products for irritation potential using Draize scale.
研究概览
简要总结
| Objective :The objective of this study is to evaluate the dermatological safety of the investigational products on healthy human subjects.Primary irritation patch test is used widely for the evaluation of safety of cosmetics in humans. |
Sample Size :Twenty four (male and female, in a ratio of 1:1) adult subjects in the age group of 18 years to 55 years (both inclusive)
Primary skin irritation results from reversible inflammatory changes in the skin following the application of a test substance.
By this test, irritation potential of a substance is assessed by a single application of patch under complete occlusion for 24 hrs and is done as per BIS standard (IS4011:1997)
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- All
入选标准
- •Healthy male and female subjects in the age group of 18-55 years (both age inclusive)
- •Subjects with Fitzpatrick skin type III to V
- •Subjects willing to give a voluntary written informed consent
- •Subjects having not participated in a similar investigation in the past two weeks
- •Subjects willing to come for regular follow up visits
- •Subjects without any open wounds, cuts, abrasions, irritation symptoms.
排除标准
- •Subjects with Infection/ allergy/ irritation symptoms on the upper back area identified for patch application
- •Subjects with any kind of skin allergy, antecedents or atopy or cutaneous disease which may influence the study results
- •Subject is Pregnant or Lactating
- •Athletes and subjects with history of excessive sweating
- •Subjects participating in any other cosmetic or therapeutic trial
- •Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
结局指标
主要结局
Safety assessment of investigational products for irritation potential using Draize scale.
时间窗: Draize scoring to be done at 0 hr, 24 hr and day 7 of patch removal
次要结局
- N/A(N/A)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
24hrs occlusive Primary irritation Patch test on healthy human volunteersCTRI/2018/02/012014ITC Life Sciences Technology Centre24
招募中
不适用
24hrs skin sensitivity patch test on healthy human volunteers.CTRI/2017/08/009239Dabur India Limited24
已完成
不适用
24 hrs primary irritation patch test on healthy human volunteersCTRI/2013/05/003638Emami ltd24
已完成
不适用
24 hours Primary Irritation patch test on healthy human volunteersCTRI/2013/03/003471ITC RD Centre24
已完成
Unknown
Checking of safety of productsCTRI/2024/04/065604ITC LIMITED24